本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

195.70
-0.2200-0.11%
成交量:98.59萬
成交額:1.97億
市值:419.46億
市盈率:-21.94
高:202.02
開:198.53
低:195.69
收:195.92
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:0.92
換手率:0.53%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.09
市盈率(LYR):-32.89

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]